Technical Quinalphos was administered po to pregnant rats through day
6-20 of gestation at doses of 0.5 or 1.5 mg/kg body weight. Quinalphos
produced enzymatic changes in liver and serum of dams associated with
mild pathomorphological changes in liver and brain. Fetotoxic effects
were not observed at the tested dose levels as determined by total nu
mber of implantations, percentage resorption, live fetuses, crown rump
length and fetal weight. A few insignificant skeletal deformities wer
e noticed. A significant inhibition of acetylcholinesterase activity i
n fetal brain and placenta indicated possible transmigration of quinal
phos from dams to fetuses.